Drug Shortage Report for JAMP-AMLODIPINE

Last updated on 2021-07-30 History
Report ID 3489
Drug Identification Number 02357186
Brand name JAMP-AMLODIPINE
Common or Proper name Amlodipine besilate
Company Name JAMP PHARMA CORPORATION
Market Status MARKETED
Active Ingredient(s) AMLODIPINE
Strength(s) 2.5MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code C08CA
ATC description SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-03-01
Estimated end date
Actual end date 2021-04-21
Shortage status Resolved
Updated date 2021-07-30
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1310 RUE NOBEL
BOUCHERVILLE, QUEBEC
CANADA J4B 5H3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v28 2021-07-30 French Compare
v27 2021-07-30 English Compare
v26 2020-02-18 French Compare
v25 2020-02-18 English Compare
v24 2019-03-01 French Compare
v23 2019-03-01 English Compare
v22 2018-12-19 French Compare
v21 2018-12-19 English Compare
v20 2018-12-19 English Compare
v19 2018-10-15 French Compare
v18 2018-10-15 English Compare
v17 2017-11-21 French Compare
v16 2017-11-21 English Compare
v15 2017-09-25 French Compare
v14 2017-09-25 English Compare
v13 2017-09-25 English Compare
v12 2017-09-25 English Compare
v11 2017-08-08 French Compare
v10 2017-08-08 English Compare
v9 2017-07-12 French Compare

Showing 1 to 20 of 28